Tcg Crossover Management, LLC Savara Inc Transaction History
Tcg Crossover Management, LLC
- $415 Million
- Q1 2025
A detailed history of Tcg Crossover Management, LLC transactions in Savara Inc stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 12,362,205 shares of SVRA stock, worth $33.7 Million. This represents 8.25% of its overall portfolio holdings.
Number of Shares
12,362,205
Previous 12,362,205
-0.0%
Holding current value
$33.7 Million
Previous $38 Million
9.77%
% of portfolio
8.25%
Previous 6.2%
Shares
2 transactions
Others Institutions Holding SVRA
# of Institutions
140Shares Held
162MCall Options Held
54.8KPut Options Held
4.1K-
Nea Management Company, LLC Timonium, MD24.5MShares$66.8 Million6.43% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA17.6MShares$48 Million16.36% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA11.5MShares$31.3 Million2.0% of portfolio
-
Vestal Point Capital, LP New York, NY11MShares$30 Million2.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.12MShares$22.2 Million0.0% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $311M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.